Recent Quotes

My Watchlist

Indicators

Equillium, Inc. - Common Stock (NQ: EQ )

0.6080 +0.0080 (+1.33%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	110,873
Open	0.5800
Bid (Size)	0.5837 (2)
Ask (Size)	0.6075 (13)
Prev. Close	0.6000
Today's Range	0.5800 - 0.6148
52wk Range	0.5605 - 3.250
Shares Outstanding	34,414,149
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates

November 13, 2024

From Equillium, Inc.

Via Business Wire

Equillium to Present at the Stifel Healthcare Conference

November 13, 2024

From Equillium, Inc.

Via Business Wire

Performance

YTD	-17.20%	-17.20%
1 Month	-15.56%	-15.56%
3 Month	-23.90%	-23.90%
6 Month	-10.68%	-10.68%
1 Year	-7.46%	-7.46%

More News

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

November 12, 2024

From Equillium Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session

October 31, 2024

Via Benzinga

Equillium Maintains Rights to Itolizumab Following Ono Partnership

October 31, 2024

From Equillium Inc.

Via Business Wire

Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

October 31, 2024

Via Benzinga

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

October 07, 2024

From Equillium, Inc.

Via Business Wire

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit

September 10, 2024

From Equillium, Inc.

Via Business Wire

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

September 04, 2024

From Equillium, Inc.

Via Business Wire

Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference

August 28, 2024

From Equillium, Inc.

Via Business Wire

EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q2 2024

August 09, 2024

Via InvestorPlace

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights

August 08, 2024

From Equillium Inc.

Via Business Wire

Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

August 06, 2024

From Equillium, Inc.

Via Business Wire

Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance

July 18, 2024

From Equillium, Inc.

Via Business Wire

Equillium to Participate in Upcoming Investor Conferences

July 02, 2024

From Equillium, Inc.

Via Business Wire

Equillium to be included in the Russell Microcap® Index

June 12, 2024

From Equillium, Inc.

Via Business Wire

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 05, 2024

From Equillium, Inc.

Via Business Wire

Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings

June 04, 2024

Via Benzinga

Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

June 04, 2024

Via Benzinga

Nano-Cap Equillium Shares Fall After Patchy Hair Loss Study Data

June 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session

June 04, 2024

Via Benzinga

Gold Down 1%; Bath & Body Works Shares Tumble After Q1 Results

June 04, 2024

Via Benzinga

US Stocks Lower; Donaldson Earnings Beat Views

June 04, 2024

Via Benzinga

Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata

June 04, 2024

From Equillium Inc.

Via Business Wire

Equillium to Present at the Jefferies Global Healthcare Conference

May 29, 2024

From Equillium, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.